WASHINGTON--(BUSINESS WIRE)--Jun 6, 2018--The Biotechnology Innovation Organization (BIO) is pleased to announce the establishment of the Henri A. Termeer Biotechnology Visionary Award – created in honor of the late Genzyme CEO who was instrumental in transforming Boston into a thriving hub of life science research, development and innovation.

The award was presented today in Boston at the 2018 BIO International Convention to Dr. Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation, to recognize her innovative accomplishments in cancer and infectious disease treatment. As a pioneer in healthcare for more than 30 years – and a “hero to legions of cancer patients” as reported by Forbes in 2009 – Dr. Desmond-Hellmann has devoted her career to eradicating disease, poverty and inequity.

“It is only fitting that an award to honor our dear friend and role model, Henri Termeer, be given to Dr. Sue Desmond-Hellmann – a visionary leader whose work has helped millions,” said Jim Greenwood, President and CEO of BIO. “We’re proud to honor his profound impact by recognizing her dedication to patient care and enthusiasm for innovation – traits that Henri held dear.”

Termeer’s lifelong commitment to the industry contributed not only to his lasting success, but his respect as a leader, entrepreneur, innovator, mentor and businessman. His accomplishments were admirable and extensive, from the creation of Genzyme to his leadership in the orphan rare disease community.

From this year forward, BIO will recognize one individual annually who reflects the leader’s innovative spirit and transformative impact on patient lives.

Follow the BIO 2018 Convention @BIOConvention and join the conversation @IAmBIOtech.

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the  BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW  is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter.  Subscribe to the BIO Newsletter.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180606005270/en/

CONTACT: Biotechnology Innovation Organization

Theresa Brady, 202-997-9034

Web:www.bio.org

Blog:www.biotech-now.org

Twitter:@IAmBiotech

KEYWORD: UNITED STATES NORTH AMERICA DISTRICT OF COLUMBIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY INFECTIOUS DISEASES ONCOLOGY RESEARCH SCIENCE

SOURCE: Biotechnology Innovation Organization

Copyright Business Wire 2018.

PUB: 06/06/2018 10:30 AM/DISC: 06/06/2018 10:30 AM

http://www.businesswire.com/news/home/20180606005270/en